EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease

Joanna Kujawska, Robert Zeiser, Lidia Gil

Annals of Hematology · 2025-02 · 104 (2) · 855-865

DOI: 10.1007/s00277-024-05952-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Hematology, online erschienen am 29.08.2024. Verfasst von Joanna Kujawska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland. kujawska.joannam@gmail.com. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Gastrointestinal Diseases, Steroids. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute Graft versus Host Disease (aGvHD) is a common immunological complication occurring in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Moreover, aGvHD is associated with a higher risk of infections and metabolic complications, affecting non-relapse mortality. Progress in transplantation has changed the prophylactic and therapeutic strategies of aGvHD and improved patient outcomes. The standard first-line therapy remains steroids, with a response rate of about 50%. The Janus Kinase 2 (JAK2) inhibitor, ruxolitinib, is an effective second-line therapy. The management of patients who developed a disease that is refractory to steroids and ruxolitinib, especially in the severe gastrointestinal forms of aGvHD, is not validated and remains an unmet medical need. In the article, we present the current clinical practice, as well as the latest advances targeting pathophysiological pathways of GvHD and gut microbiota, which may be a potential future of aGvHD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationGastrointestinal DiseasesSteroidsDrug ResistanceHumansAcute DiseaseGastrointestinal MicrobiomePyrimidinesNitrilesPyrazolesDisease ResistanceJanus Kinase 2

Stichwörter der Autor:innen

Graft versus host disease (GvHD)Gut microbiotaHematopoietic stem cell transplantation (HSCT)Steroid-resistant GvHD (SR-GvHD)

Substanzen

SteroidsruxolitinibPyrimidinesNitrilesPyrazolesJanus Kinase 2

Autor:innen und Institutionen

  • Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland. kujawska.joannam@gmail.com.
  • Department of Internal Medicine I, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland.

Zitieren

APA

Kujawska, J., Zeiser, R., & Gil, L. (2025). Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease. Annals of Hematology, 104(2), 855-865. https://doi.org/10.1007/s00277-024-05952-0

Vancouver

Kujawska J, Zeiser R, Gil L. Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease. Annals of Hematology. 2025;104(2):855-865. doi:10.1007/s00277-024-05952-0

BibTeX
@article{Kujawska2025,
  author = {Kujawska, Joanna and Zeiser, Robert and Gil, Lidia},
  title = {Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {2},
  pages = {855--865},
  doi = {10.1007/s00277-024-05952-0}
}
Kostenlos starten →